Dr. Fadi Braiteh is a hematologist / oncologist in Las Vegas. He is a cancer specialist trained in blood disorders and the medical treatment of malignancies.
Please Note: This link will direct you to a third-party website unaffiliated with MD.com (http://www.cccnevada.com/patient-resources/your-first-appointment/schedul-appointment/), where you're able to request or schedule an appointment online with Dr. Fadi Braiteh.
Yes, Dr. Fadi S. Braiteh is accepting new patients at this office.
3730 S. Eastern Avenue, Las Vegas, NV 89169
Open | Lunch | Close | |
---|---|---|---|
Mon | — | ||
Tue | — | ||
Wed | — | ||
Thu | — | ||
Fri | — |
Fadi S. Braiteh is a medical oncologist and clinical researcher at Comprehensive Cancer Centers of Nevada (CCCN) where he serves as a principal investigator for numerous research trials though UCLA-TRIO-US and US Oncology Research network, mostly in gastrointestinal and thoracic malignancies. Additionally, Dr. Braiteh directs the Translational Oncology Program (TOP-Phase I) at CCCN for the development of novel anti-cancer agents. He is a certified physician investigator, board certified in internal medicine, palliative medicine and medical oncology with expertise in gastro-intestinal and thoracic oncology.
Prior to CCCN, Dr. Braiteh was the director of Phase I program and developmental therapeutics at the Cancer and Hematology Centers of Western Michigan. During this time, he was a clinical assistant professor of medicine at the School of Human Medicine at Michigan State University, and scientific investigator for Program of Translational Medicine and Phase 1 clinical trials at Van Andel Research Institute in Grand Rapids, Michigan.
Dr. Braiteh is a member of the lecturing faculty with numerous professional societies including American Society of Clinical Oncology, American Medical Association, Academy of Clinical Research Professionals, and Academy of Pharmaceutical Physicians and Investigators. He has authored and co-authored more than 50 original peer-reviewed manuscripts, abstracts and book chapters.
Dr. Braiteh has been featured in The New York Times in relation to his work with gene mutations and he has been repeatedly named among America’s top medical oncologists by Castle-Connolly, US News & World Report and Las Vegas Life. He has also received numerous honors including “Medical Marvel” from Nevada Business magazine, the Patients Top Choice Award, Top Researcher Award, Susan G. Komen for the Cure Award, the M.D. Anderson Cancer Center Employee Achievement Award and the ASCO Foundation Merit Award among others.
Dr. Braiteh received his medical degree from Saint Joseph University in Beirut, Lebanon. Following a residency in internal medicine at the Yale School of Medicine in New Haven, Connecticut, he completed three fellowships in palliative care and hospice medicine, Phase I drug development and medical oncology at the University of Texas M. D. Anderson Cancer Center in Houston, Texas.
As a hematologist / oncologist in Nevada, Dr. Braiteh is capable of diagnosing and treating patients with blood-related disorders, malignancies, or cancers. Dr. Braiteh may treat a range of conditions ranging from the the common to the very rare and complex. As a result, Dr. Braiteh may provide care as part of a multidisciplinary team, working in conjunction with other specialists to ensure the highest possible standard of care.
Palliative care physicians provide specialized medical care for people living with serious illness. Doctors who specialize in palliative care focus on providing relief from symptoms and stress, offering care that is focused on improving quality of life for both the patient and the family. Palliative care is appropriate at any age, and at any stage in a serious illness, and can be provided along with curative treatment.
St. Joseph's University Medical School
MD • 1998
Hospital of Saint Raphael, Yale School of Medicine • New Haven, CT
Residency in Internal Medicine
• 2000 - 2003